Alphatec Holdings, Inc. is a medical technology company that specializes in the design, development, and advancement of surgical technologies for spinal disorder treatments. The company's product offerings include the SafeOp Neural InformatiX System, aimed at minimizing intraoperative nerve injury risk, and the Sigma transforaminal lumbar interbody fusion pedicle-based access system, which allows for direct visualization of anatomical landmarks. Additionally, the portfolio features the Sigma PTP Access and Patient Positioning System, the squadron lateral retractor to enhance patient outcomes, and the Invictus Spinal Fixation System, designed for thoracolumbar fixation to address various pathologies. Further bolstering its innovations, the Invictus MIS SingleStep System enables minimally invasive pedicle screw placements. Alphatec also provides modular fixation solutions with the Invictus Modular Fixation Systems, along with the OsseoScrew system that aims to restore spinal column integrity. Other key offerings include the Arsenal spinal fixation system for a range of conditions, the Aspida Anterior Lumbar Plating System for anterior lumbar interbody fusion, the AMP Anti-Migration Plate, the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Moreover, Alphatec produces IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants, along with a range of biologics such as Cervical Structural Allograft Spacers and the 3D ProFuse Demineralized Bone Scaffold. The financial data pertains to the fiscal year 2025 where the company incurred an income tax expense of -$45,000.00 indicating its tax obligations, while its net income ratio is -0.19 reflecting the company's profitability margin. Additionally, Alphatec earned an interest income of $0.00 showcasing its financial investments, while total costs and expenses amount to $846,283,000.00 highlighting overall spending. The company's stock is affordable at $15.54 making it suitable for budget-conscious investors, while a high average trading volume of 3,018,266.00 indicates strong liquidity. With a market capitalization of $1,916,174,809.00 Alphatec is classified as a small-cap player. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape, and it belongs to the Healthcare sector, where it drives innovation and growth.